The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson's disease

Folia Neuropathologica

Volumn 52, Issue 3, 2014, Pages 260-269

  Pyszko, Joanna A ^a   Strosznajder, Joanna B ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Apoptosis; Dopaminergic neurons; PD model; Sphingosine kinases

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA SYNUCLEIN; BH3 PROTEIN; CASPASE; CASPASE INHIBITOR; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE; SPHINGOSINE KINASE 2, HUMAN; TRANSCRIPTOME;

ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL; NEUROBLASTOMA CELL LINE; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN SECRETION; APOPTOSIS; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TRANSFECTION;

EID: 84907529805     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2014.45567     Document Type: Article

References (59)

1. Abbott SK, Li H, Muñoz SS, Knoch B., Batterham M, Murphy KE, Halliday G.M., Garner B. Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease. Mov Disord 2014; 29: 518-526.
2. Adamczyk A, Kacprzak M, Kazmierczak A. Alpha-synuclein de creases arachidonic acid incorporation into rat striatal sy na-pto neurosomes. Folia Neuropathol 2007; 45: 230-235.
3. Bektas M, Jolly PS, Müller C, Eberle J., Spiegel S, Geilen CC. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 2005; 24: 178-187.
4. Betito S, Cuvillier O. Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. Biochem Biophys Res Commun 2006; 340: 1273-1277.
5. Brugg B, Michel PP, Agid Y, Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. Neurochem J 1996; 66: 733-739.
6. Ceccom J, Loukh N, Lauwers-Cances V, Touriol C., Nicaise Y, Gentil C, Uro-Coste E, Pitson S., Maurage CA, Duyckaerts C, Cuvillier O, Delisle MB Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease. Acta Neuropathol Commun 2014; 2: 12.
7. Cheng D, Jenner AM, Shui G, Cheong W.F., Mitchell TW, Nealon JR, Kim WS, McCann H, Wenk M.R., Halliday GM, Garner B. Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS One 2011; 6: e17299.
8. Cieslik M, Pyszko J, Strosznajder JB Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/ genotoxic stress treatment. Neurochem Int 2013; 62: 626-636.
9. Colié S, Van Veldhoven PP, Kedjouar B, Bedia C, Albinet V, Sorli SC, Garcia V Djavaheri-Mergny M, Bauvy C, Codogno P, Levade T, Andrieu-Abadie N. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL up-regulation. Cancer Res 2009; 69: 9346-9353.
10. Couttas TA, Kain N, Daniels B., Lim XY, Shepherd C, Kril J, Pickford R., Li H, Garner B, Don AS Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease patho-genesis. Acta Neuropathol Commun 2014; 2: 9.
11. Czubowicz K, Strosznajder R. Ceramide in the Molecular Mechanisms of Neuronal Cell Death. The Role of Sphingosine-1-Phos-phate. Mol Neurobiol 2014; doi: 10.1007/s12035-013-8606-4.
12. Datta SR, Dudek H, Tao X., Masters S, Fu H, Gotoh Y., Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241.
13. Edsall LC, Pirianov GG, Spiegel S. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J Neurosci 1997; 17: 6952-6960.
14. Fabelo N, Martín V, Santpere G., Marín R, Torrent L., Ferrer I, Díaz M. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol Med 2011; 17: 1107-1118.
15. Fortin DL, Troyer MD, Nakamura K, Kubo S., Anthony MD, Edwards RH. Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 2004; 24: 6715-6723.
16. Fyrst H, Saba JD An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010; 6: 489-497.
17. Giasson B, Duda JE, Murray I V, Chen Q, Souza J.M., Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000; 290: 985-989.
18. Gómez-Santos C., Ferrer I, Reiriz J., Viñals F, Barrachina M., Ambrosio S. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res 2002; 935: 32-39.
19. Hait NC, Allegood J, Maceyka M., Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R., Kordula T, Milstien S, Spiegel S. Regulation of histone acetylation in the nucleus by sphin-gosine-1-phosphate. Science 2009; 325: 1254-1257.
20. Hansen C, Angot E, Bergström AL, Steiner J.A., Pieri L., Paul G, Outeiro T F, Melki R, Kallunki P, Fog K, Li JY, Brundin P. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011; 121: 715-725.
21. He X, Huang Y, Li B., Gong CX, Schuchman EH. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 2010; 31: 398-408.
22. Igarashi N, Okada T, Hayashi S., Fujita T, Jahangeer S, Nakamura S. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 2003; 278: 46832-46839.
23. Katsel P, Li C, Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 2007; 32: 845-856.
24. Korecka JA, van Kesteren RE, Blaas E, Spitzer SO, Kamstra J.H., Smit AB, Swaab D F, Verhaagen J, Bossers K. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by tran-scriptional profling. PLoS One 2013; 8: e63862.
25. Lee HJ, Bae EJ, Lee SJ Extracellular α-synuclein-a novel and crucial factor in Lewy body diseases. Nat Rev Neurol 2014; 10: 92-98.
26. Li Q.F., Wu CT, Guo Q, Wang H., Wang LS. Sphingosine 1-phos-phate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. Biochem Biophys Res Commun 2008; 371: 159-162.
27. Limaye V, Li X, Hahn C., Xia P, Berndt MC, Vadas M.A., Gamble JR. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 2005; 105: 3169-3177.
28. Lwin A, Orvisky E, Goker-Alpan O, LaMarca M.E., Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004; 81: 70-73.
29. Maceyka M, Sankala H, Hait N.C., Le Stunf H, Liu H, Toman R., Collier C, Zhang M, Satin L.S., Merrill AH Jr, Milstien S, Spiegel S. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 2005; 280: 37118-37129.
30. Martinez TN, Chen X, Bandyopadhyay S., Merrill AH, Tansey MG. Ceramidesphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopami-nergic neurons. Mol Neurodegener 2012; 7: 45.
31. Means CK, Xiao C Y, Li Z, Zhang T., Omens JH, Ishii I, Chun J, Brown JH Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfu-sion injury. Am J Physiol Heart Circ Physiol 2007; 292: H2944-2951.
32. Meyerzu Heringdorf D, Lass H, Kuchar I, Lipinski M, Alemany R, Rumenapp U, Jakobs KH. Stimulation of intracellular sphingo-sine-1-phosphate production by G-protein-coupled sphingo sine-1-phosphate receptors. Eur J Pharmacol 2001; 414: 145-154.
33. Mizugishi K, Yamashita T, Olivera A., Miller G F, Spiegel S, Proia RL Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005; 25: 11113-11121.
34. Murphy KE, Gysbers AM, Abbott S.K., Tayebi N., Kim WS, Sidransky E, Cooper A, Garner B., Halliday GM. Reduced glucocerebro-sidase is associated with increased α-synuclein in sporadic Parkinson's disease. Brain 2014; 137: 834-848.
35. Nakahara T, Iwase A, Nakamura T., Kondo M, Bayasula, Kobayashi H, Takikawa S, Manabe S, Goto M, Kotani T, Kikkawa F. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertil Steril 2012; 98: 1001-1008.
36. Neubauer HA, Pitson SM Roles, regulation and inhibitors of sphingosine kinase 2. FEBS J 2013; 280: 5317-5336.
37. Orr Gandy K.A., Obeid LM Targeting the sphingosine kinase/sphin-gosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim Biophys Acta 2013; 1831: 157-166.
38. Oyarce AM, Fleming PJ Multiple forms of human dopamine beta-hydroxylase in SH-SY5Y neuroblastoma cells. Arch Biochem Biophys 1991; 290: 503-510.
39. Pitson SM, Moretti PA, Zebol J.R., Lynn HE, Xia P, Vadas MA, Wattenberg BW Activation of sphingosine kinase 1 by ERK1/2-me-diated phosphorylation. EMBO J 2003; 22: 5491-5500.
40. Polymeropoulos MH, Lavedan C, Leroy E., Ide SE, Dehejia A, Dutra A, Pike B, Root H., Rubenstein J, Boyer R, Stenroos E.S., Chandrasekharappa S, Athanassiadou A, Papapetropoulos T., Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
41. Pyszko J, Strosznajder JB Sphingosine Kinase 1 and Sphingo sine-1-Phosphate in Oxidative Stress Evoked by 1-Methyl-4-Phenyl-pyridinium (MPP+) in Human Dopaminergic Neuronal Cells. Mol Neurobiol 2014; doi: 10.1007/s12035-013-8622-4 [Epub ahead of print].
42. Rosenquist M. 14-3-3 proteins in apoptosis. Braz J Med Biol Res 2003; 36: 403-408.
43. Sauer B, Gonska H, Manggau M., Kim DS, Schraut C, Schäfer-Korting M, Kleuser B. Sphingosine 1-phosphate is involved in cyto-protective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2/Bax rheostat. Pharmazie 2005; 60: 298-304.
44. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4: 397-407.
45. Stahelin RV, Hwang JH, Kim J.H., Park ZY, Johnson KR, Obeid LM, Cho W. The mechanism of membrane targeting of human sphingosine kinase 1. J Biol Chem 2005; 280: 43030-43038.
46. Sukocheva OA, Wadham C, Holmes A., Albanese N, Verrier E, Feng F., Bernal A, Derian CK, Ullrich A, Vadas M.A., Xia P. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 2006; 173: 301-310.
47. Sutherland CM, Moretti PA, Hewitt N.M., Bagley CJ, Vadas MA, Pitson SM. The calmodulin binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane. J Biol Chem 2006; 281: 11693-11701.
48. Szanto A, Bognar Z, Szigeti A., Szabo A, Farkas L, Gallyas F Jr. Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells. Anticancer Res 2009; 29: 159-164.
49. Taha TA, Argraves KM, Obeid LM Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim Biophys Acta 2004; 1682: 48-55.
50. Takabe K, Paugh SW, Milstien S, Spiegel S. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008; 60: 181-195.
51. Takahashi T, Deng Y, Maruyama W., Dostert P, Kawai M, Naoi M. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihy-droxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm Gen Sect 1994; 98: 107-118.
52. Takasugi N, Sasaki T, Suzuki K., Osawa S, Isshiki H, Hori Y., Shimada N, Higo T, Yokoshima S., Fukuyama T, Lee VM, Trojanowski J.Q., Tomita T., Iwatsubo T. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J Neurosci 2011; 31: 6850-6857.
53. Takuwa Y, Okamoto Y, Yoshioka K., Takuwa N. Sphingosine-1-phosphate signaling in physiology and diseases. Biofactors 2012; 38: 329-337.
54. Uversky VN, Eliezer D. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 2009; 10: 483-499.
55. Van Brocklyn J.R., Williams JB The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B Biochem Mol Biol 2012; 163: 26-36.
56. Wilkaniec A, Strosznajder JB, Adamczyk A. Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration. Neurochem Int 2013; 62: 776-783.
57. Wu F, Poon WS, Lu G, Wang A., Meng H, Feng L, Li Z., Liu S. Alpha-synuclein knockdown attenuates MPP+ induced mito-chondrial dysfunction of SH-SY5Y cells. Brain Res 2009; 1292: 173-179.
58. Xia P, Wang L, Moretti P.A., Albanese N., Chai F, Pitson SM, D'Andrea RJ, Gamble JR, Vadas MA Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem 2002; 277: 7996-8003.
59. Xie HR, Hu LS, Li GY SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl) 2010; 123: 1086-1092.